© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 13, 1042-1053,
July 5, 2000
© 2000 Oxford University Press
REVIEW |
Mitochondrion as a Novel Target of Anticancer Chemotherapy
Affiliations of authors: P. Costantini, E. Jacotot, G. Kroemer, Centre National de la Recherche Scientifique, Institut Gustave Roussy, Villejuif, France; D. Decaudin, Institut Curie, Département d'Hématologie, Paris, France.
Correspondence to: Guido Kroemer, M.D., Ph.D., 19 rue Guy Môquet, B.P. 8, F-94801 Villejuif, France (e-mail: kroemer{at}infobiogen.fr).
Mitochondrial membrane permeabilization is a critical event in the process leading to physiologic or chemotherapy-induced apoptosis (programmed cell death). This permeabilization event is, at least in part, under the control of the permeability transition pore complex (PTPC). Oncoproteins from the Bcl-2 family and tumor suppressor proteins from the Bax family interact with PTPC to inhibit or facilitate membrane permeabilization, respectively. Conventional chemotherapeutic agents elicit mitochondrial permeabilization in an indirect fashion by induction of endogenous effectors that are involved in the physiologic control of apoptosis. However, an increasing number of experimental anticancer drugs, including lonidamine, arsenite, betulinic acid, CD437, and several amphipathic cationic 
-helical peptides, act directly on mitochondrial membranes and/or on the PTPC. Such agents may induce apoptosis in circumstances in which conventional drugs fail to act because endogenous apoptosis induction pathways, such as those involving p53, death receptors, or apical caspase activation, are disrupted. However, stabilization of the mitochondrial membrane by antiapoptotic Bcl-2-like proteins reduces the cytotoxic potential of most of these drugs. Targeting of specific PTPC components may overcome this Bcl-2-mediated apoptosis inhibition. One strategy involves cross-linking of critical redox-sensitive thiol groups within the PTPC; another involves the use of ligands to the mitochondrial benzodiazepine receptor. Thus, the design of mitochondrion-targeted cytotoxic drugs may constitute a novel strategy for overcoming apoptosis resistance.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L.-K. Sy, S.-C. Yan, C.-N. Lok, R. Y.K. Man, and C.-M. Che Timosaponin A-III Induces Autophagy Preceding Mitochondria-Mediated Apoptosis in HeLa Cancer Cells Cancer Res., December 15, 2008; 68(24): 10229 - 10237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Heaney, J. R. Gardner, N. Karasavvas, D. W. Golde, D. A. Scheinberg, E. A. Smith, and O. A. O'Connor Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs Cancer Res., October 1, 2008; 68(19): 8031 - 8038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Kim, J.-H. Yoon, J.-M. Jeong, G.-J. Cheon, T.-S. Lee, J.-I. Yang, S.-C. Park, and H.-S. Lee Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma Mol. Cancer Ther., September 1, 2007; 6(9): 2554 - 2562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Rege, S. J. Patel, Z. Megeed, and M. L. Yarmush Amphipathic Peptide-Based Fusion Peptides and Immunoconjugates for the Targeted Ablation of Prostate Cancer Cells Cancer Res., July 1, 2007; 67(13): 6368 - 6375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Law, L. Quinti, Y. Choi, R. Weissleder, and C.-H. Tung A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity. Mol. Cancer Ther., August 1, 2006; 5(8): 1944 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Wang, Z. Li, Y. Lu, R. Du, S. Katiyar, J. Yang, M. Fu, J. E. Leader, A. Quong, P. M. Novikoff, et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function PNAS, August 1, 2006; 103(31): 11567 - 11572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sakamaki, M. C. Casimiro, X. Ju, A. A. Quong, S. Katiyar, M. Liu, X. Jiao, A. Li, X. Zhang, Y. Lu, et al. Cyclin d1 determines mitochondrial function in vivo. Mol. Cell. Biol., July 1, 2006; 26(14): 5449 - 5469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Hartel, F F di Mola, F Selvaggi, G Mascetta, M N Wente, K Felix, N A Giese, U Hinz, P Di Sebastiano, M W Buchler, et al. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management Gut, April 1, 2006; 55(4): 519 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kluza, M.-A. Gallego, A. Loyens, J.-C. Beauvillain, J.-M. F. Sousa-Faro, C. Cuevas, P. Marchetti, and C. Bailly Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin d. Cancer Res., March 15, 2006; 66(6): 3177 - 3187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Kim, J. J. Song, J. Y. An, Y. T. Kwon, and Y. J. Lee Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression J. Biol. Chem., December 9, 2005; 280(49): 41047 - 41056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2829 - 2839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Furre, S. Shahzidi, Z. Luksiene, M. T.N. Moller, E. Borgen, J. Morgan, K. Tkacz-Stachowska, J. M. Nesland, and Q. Peng Targeting PBR by Hexaminolevulinate-Mediated Photodynamic Therapy Induces Apoptosis through Translocation of Apoptosis-Inducing Factor in Human Leukemia Cells Cancer Res., December 1, 2005; 65(23): 11051 - 11060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. R. Fantin, M. J. Berardi, H. Babbe, M. V. Michelman, C. M. Manning, and P. Leder A Bifunctional Targeted Peptide that Blocks HER-2 Tyrosine Kinase and Disables Mitochondrial Function in HER-2-Positive Carcinoma Cells Cancer Res., August 1, 2005; 65(15): 6891 - 6900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ceruti, A. Mazzola, and M. P. Abbracchio Resistance of Human Astrocytoma Cells to Apoptosis Induced by Mitochondria-Damaging Agents: Possible Implications for Anticancer Therapy J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 825 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Wu, M.-L. Chan, W.-Y. Chen, C.-Y. Tsai, F.-R. Chang, and Y.-C. Wu Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria Mol. Cancer Ther., August 1, 2005; 4(8): 1277 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lievre, C. Chapusot, A.-M. Bouvier, F. Zinzindohoue, F. Piard, P. Roignot, L. Arnould, P. Beaune, J. Faivre, and P. Laurent-Puig Clinical Value of Mitochondrial Mutations in Colorectal Cancer J. Clin. Oncol., May 20, 2005; 23(15): 3517 - 3525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Cheng, R. C. Winant, and S. S. Gambhir A New Strategy to Screen Molecular Imaging Probe Uptake in Cell Culture Without Radiolabeling Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry J. Nucl. Med., May 1, 2005; 46(5): 878 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hu, C. Jiang, C. Ip, Y. M. Rustum, and J. Lu Methylseleninic Acid Potentiates Apoptosis Induced by Chemotherapeutic Drugs in Androgen-Independent Prostate Cancer Cells Clin. Cancer Res., March 15, 2005; 11(6): 2379 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rotem, A. Heyfets, O. Fingrut, D. Blickstein, M. Shaklai, and E. Flescher Jasmonates: Novel Anticancer Agents Acting Directly and Selectively on Human Cancer Cell Mitochondria Cancer Res., March 1, 2005; 65(5): 1984 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Ambrosone, J. Ahn, K. K. Singh, H. Rezaishiraz, H. Furberg, C. Sweeney, B. Coles, and A. Trovato Polymorphisms in Genes Related to Oxidative Stress (MPO, MnSOD, CAT) and Survival After Treatment for Breast Cancer Cancer Res., February 1, 2005; 65(3): 1105 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu, P. Yue, Z. Zhou, F. R. Khuri, and S.-Y. Sun Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells J Natl Cancer Inst, December 1, 2004; 96(23): 1769 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Denlinger, B. K. Rundall, and D. R. Jones Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liang, R. A. Salinas, B. Z. Leal, T. Kosakowska-Cholody, C. J. Michejda, S. J. Waters, T. S. Herman, J. M. Woynarowski, and B. A. Woynarowska Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells Mol. Cancer Ther., November 1, 2004; 3(11): 1385 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Krett, K. M. Davies, M. Ayres, C. Ma, C. Nabhan, V. Gandhi, and S. T. Rosen 8-Amino-adenosine is a potential therapeutic agent for multiple myeloma Mol. Cancer Ther., November 1, 2004; 3(11): 1411 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. N. Ivanov and T. K. Hei Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor {alpha}-mediated Pathway J. Biol. Chem., May 21, 2004; 279(21): 22747 - 22758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Sun, N. Hail Jr, and R. Lotan Apoptosis as a Novel Target for Cancer Chemoprevention J Natl Cancer Inst, May 5, 2004; 96(9): 662 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Keedwell, Y. Zhao, L. A. Hammond, S. Qin, K.-Y. Tsang, A. Reitmair, Y. Molina, Y. Okawa, L. I. Atangan, D.-L. Shurland, et al. A Retinoid-Related Molecule that Does Not Bind to Classical Retinoid Receptors Potently Induces Apoptosis in Human Prostate Cancer Cells through Rapid Caspase Activation Cancer Res., May 1, 2004; 64(9): 3302 - 3312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schmitt, A. Parcellier, F. Ghiringhelli, N. Casares, S. Gurbuxani, N. Droin, A. Hamai, M. Pequignot, A. Hammann, M. Moutet, et al. Increased Immunogenicity of Colon Cancer Cells by Selective Depletion of Cytochrome c Cancer Res., April 15, 2004; 64(8): 2705 - 2711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hagg, M. Berndtsson, A. Mandic, R. Zhou, M. C. Shoshan, and S. Linder Induction of endoplasmic reticulum stress by ellipticine plant alkaloids Mol. Cancer Ther., April 1, 2004; 3(4): 489 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schubert and S. Grimm Cyclophilin D, a Component of the Permeability Transition-Pore, Is an Apoptosis Repressor Cancer Res., January 1, 2004; 64(1): 85 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. R. Fantin and P. Leder F16, a Mitochondriotoxic Compound, Triggers Apoptosis or Necrosis Depending on the Genetic Background of the Target Carcinoma Cell Cancer Res., January 1, 2004; 64(1): 329 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Garattini, E. Parrella, L. Diomede, M. Gianni', Y. Kalac, L. Merlini, D. Simoni, R. Zanier, F. F. Ferrara, I. Chiarucci, et al. ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis Blood, January 1, 2004; 103(1): 194 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Boitano, J. A. Ellman, G. D. Glick, and A. W. Opipari Jr. The Proapoptotic Benzodiazepine Bz-423 Affects the Growth and Survival of Malignant B Cells Cancer Res., October 15, 2003; 63(20): 6870 - 6876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Papaldo, M. Lopez, E. Cortesi, E. Cammilluzzi, M. Antimi, E. Terzoli, G. Lepidini, P. Vici, C. Barone, G. Ferretti, et al. Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide J. Clin. Oncol., September 15, 2003; 21(18): 3462 - 3468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Rajesh, S. Sasaguri, Z. Zhitian, R. Suzuki, R. Asakai, and H. Maeda Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression Cardiovasc Res, August 1, 2003; 59(2): 297 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Lash The Mitochondrial Benzodiazepine Receptor as a Potential Target Protein for Drug Development: Demonstration of Functional Significance with Cell Lines Exhibiting Differential Expression of Bcl-2 Toxicol. Sci., July 1, 2003; 74(1): 1 - 3. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Muscarella, K. A. O'Brien, A. T. Lemley, and S. E. Bloom Reversal of Bcl-2-Mediated Resistance of the EW36 Human B-Cell Lymphoma Cell Line to Arsenite- and Pesticide-Induced Apoptosis by PK11195, a Ligand of the Mitochondrial Benzodiazepine Receptor Toxicol. Sci., July 1, 2003; 74(1): 66 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Ortega, J. Carretero, E. Obrador, J. Gambini, M. Asensi, V. Rodilla, and J. M. Estrela Tumor Cytotoxicity by Endothelial Cells. IMPAIRMENT OF THE MITOCHONDRIAL SYSTEM FOR GLUTATHIONE UPTAKE IN MOUSE B16 MELANOMA CELLS THAT SURVIVE AFTER IN VITRO INTERACTION WITH THE HEPATIC SINUSOIDAL ENDOTHELIUM J. Biol. Chem., April 11, 2003; 278(16): 13888 - 13897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Berge, K. J. Tronstad, P. Bohov, L. Madsen, and R. K. Berge Impact of mitochondrial {beta}-oxidation in fatty acid-mediated inhibition of glioma cell proliferation J. Lipid Res., January 1, 2003; 44(1): 118 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lansiaux, F. Tanious, Z. Mishal, L. Dassonneville, A. Kumar, C. E. Stephens, Q. Hu, W. D. Wilson, D. W. Boykin, and C. Bailly Distribution of Furamidine Analogues in Tumor Cells: Targeting of the Nucleus or Mitochondria Depending on the Amidine Substitution Cancer Res., December 15, 2002; 62(24): 7219 - 7229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Holmes, D. R. Soprano, and K. J. Soprano Elucidation of Molecular Events Mediating Induction of Apoptosis by Synthetic Retinoids Using a CD437-resistant Ovarian Carcinoma Cell Line J. Biol. Chem., November 15, 2002; 277(47): 45408 - 45419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Castedo, J.-L. Perfettini, and G. Kroemer Mitochondrial Apoptosis and the Peripheral Benzodiazepine Receptor: A Novel Target for Viral and Pharmacological Manipulation J. Exp. Med., November 4, 2002; 196(9): 1121 - 1126. [Full Text] [PDF]
|
|
|
|
|
|
N. Hail Jr. and R. Lotan Examining the Role of Mitochondrial Respiration in Vanilloid-Induced Apoptosis J Natl Cancer Inst, September 4, 2002; 94(17): 1281 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Fernandez, L. Troiano, L. Moretti, M. Nasi, M. Pinti, S. Salvioli, J. Dobrucki, and A. Cossarizza Early Changes in Intramitochondrial Cardiolipin Distribution during Apoptosis Cell Growth Differ., September 1, 2002; 13(9): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mizutani, S. Tada-Oikawa, Y. Hiraku, S. Oikawa, M. Kojima, and S. Kawanishi Mechanism of Apoptosis Induced by a New Topoisomerase Inhibitor through the Generation of Hydrogen Peroxide J. Biol. Chem., August 16, 2002; 277(34): 30684 - 30689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Ferreira, M. Epping, F. A. E. Kruyt, and G. Giaccone Apoptosis: Target of Cancer Therapy Clin. Cancer Res., July 1, 2002; 8(7): 2024 - 2034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Barrett, F. L. Lewis, J. B. Roaten, T. W. Sweatman, M. Israel, J. L. Cleveland, and L. Lothstein Novel Extranuclear-targeted Anthracyclines Override the Antiapoptotic Functions of Bcl-2 and Target Protein Kinase C Pathways to Induce Apoptosis Mol. Cancer Ther., May 1, 2002; 1(7): 469 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Decaudin, M. Castedo, F. Nemati, A. Beurdeley-Thomas, G. De Pinieux, A. Caron, P. Pouillart, J. Wijdenes, D. Rouillard, G. Kroemer, et al. Peripheral Benzodiazepine Receptor Ligands Reverse Apoptosis Resistance of Cancer Cells in Vitro and in Vivo Cancer Res., March 1, 2002; 62(5): 1388 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Szewczyk and L. Wojtczak Mitochondria as a Pharmacological Target Pharmacol. Rev., March 1, 2002; 54(1): 101 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Jones, R. M. Broad, L. D. Comeau, S. J. Parsons, and M. W. Mayo Inhibition of nuclear factor {kappa}B chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 310 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wosikowski, K. Mattern, I. Schemainda, M. Hasmann, B. Rattel, and R. Loser WK175, a Novel Antitumor Agent, Decreases the Intracellular Nicotinamide Adenine Dinucleotide Concentration and Induces the Apoptotic Cascade in Human Leukemia Cells Cancer Res., February 1, 2002; 62(4): 1057 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Cen, R. I. Gonzalez, J. A. Buckmeier, R. S. Kahlon, N. B. Tohidian, and F. L. Meyskens Jr Disulfiram Induces Apoptosis in Human Melanoma Cells: A Redox-related Process Mol. Cancer Ther., January 1, 2002; 1(3): 197 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hail Jr. and R. Lotan Mitochondrial Respiration Is Uniquely Associated with the Prooxidant and Apoptotic Effects of N-(4-Hydroxyphenyl)retinamide J. Biol. Chem., November 30, 2001; 276(49): 45614 - 45621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hail Jr., E. M. Youssef, and R. Lotan Evidence Supporting a Role for Mitochondrial Respiration in Apoptosis Induction by the Synthetic Retinoid CD437 Cancer Res., September 1, 2001; 61(18): 6698 - 6702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Phenix, J. J. Lum, Z. Nie, J. Sanchez-Dardon, and A. D. Badley Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss Blood, August 15, 2001; 98(4): 1078 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Dirsch, H. Stuppner, and A. M. Vollmar Helenalin Triggers a CD95 Death Receptor-independent Apoptosis That Is Not Affected by Overexpression of Bcl-xL or Bcl-2 Cancer Res., August 1, 2001; 61(15): 5817 - 5823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pervin, R. Singh, C.-L. Gau, H. Edamatsu, F. Tamanoi, and G. Chaudhuri Potentiation of Nitric Oxide-induced Apoptosis of MDA-MB-468 Cells by Farnesyltransferase Inhibitor: Implications in Breast Cancer Cancer Res., June 1, 2001; 61(12): 4701 - 4706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Dumon, H. Ishii, A. Vecchione, F. Trapasso, G. Baldassarre, F. Chakrani, T. Druck, E. F. Rosato, N. N. Williams, R. Baffa, et al. Fragile Histidine Triad Expression Delays Tumor Development and Induces Apoptosis in Human Pancreatic Cancer Cancer Res., June 1, 2001; 61(12): 4827 - 4836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Haridas, M. Higuchi, G. S. Jayatilake, D. Bailey, K. Mujoo, M. E. Blake, C. J. Arntzen, and J. U. Gutterman Avicins: Triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation PNAS, May 8, 2001; 98(10): 5821 - 5826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-S. Belzacq, E. Jacotot, H. L. A. Vieira, D. Mistro, D. J. Granville, Z. Xie, J. C. Reed, G. Kroemer, and C. Brenner Apoptosis Induction by the Photosensitizer Verteporfin: Identification of Mitochondrial Adenine Nucleotide Translocator as a Critical Target Cancer Res., February 1, 2001; 61(4): 1260 - 1264. [Abstract] [Full Text]
|
|
|
|
|
|
A. A. Ruefli, M. J. Ausserlechner, D. Bernhard, V. R. Sutton, K. M. Tainton, R. Kofler, M. J. Smyth, and R. W. Johnstone The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species PNAS, September 11, 2001; 98(19): 10833 - 10838. [Abstract] [Full Text] [PDF]
|
|